| Ms Aimee Kathleen Doran, CPNP | |
|
13123 E 16th Ave # B-100, Aurora, CO 80045-7106 | |
| (720) 777-5825 | |
| (720) 777-7290 |
| Full Name | Ms Aimee Kathleen Doran |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 13123 E 16th Ave # B-100, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023283975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | 86726 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Aimee Kathleen Doran, CPNP 13123 E 16th Ave # B-100, Aurora, CO 80045-7106 Ph: (720) 777-5825 | Ms Aimee Kathleen Doran, CPNP 13123 E 16th Ave # B-100, Aurora, CO 80045-7106 Ph: (720) 777-5825 |
News Archive
Researchers at The Medicines Company presented data from a multi-national cohort that demonstrates the mortality and morbidity, and poor outcomes, associated with current therapies in patients with infections due to carbapenem-resistant Enterobacteriaceae (CRE). The data from this analysis has guided the design of the company's on-going clinical studies of its Phase 3 compound, CARBAVANCE® (meropenem/RPX7009) and was presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of Chemotherapy and Infection (ICC) joint meeting in San Diego, CA.
Researchers have identified a peptide and hormone that when administered to a specific area of the brain may reduce the desire for food. The study, which appears in the journal Neuropsychopharmacology, may one day lead to medications that treat obesity and binge eating disorders.
Deep Longevity, Inc (DLI), a leader in artificial intelligence for aging and longevity research announced that it had entered into the agreement to be acquired by Regent Pacific to create the integrated global platform for longevity biotechnology and aging research.
Research by the University of Kent into the effects of brain stimulation on athletes' performance has demonstrated that it is an effective way to improve endurance.
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.
› Verified 9 days ago
Mrs. Kristen L Holder, FNP-C, APRN-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kate Coleman Minahan, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Mrs. Jill M Marks, RN, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristi Wharton Swim, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Lauren Reed, C.P.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Ashley Wigington, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14221 E 4th Ave Ste 2-126, Aurora, CO 80011 Phone: 720-507-4779 Fax: 720-367-5067 | |
Brianna Bogdajewicz, Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 791 Chambers Rd, Aurora, CO 80011 Phone: 303-617-2300 |